empanelment of drug testing laboratories - Kerala Medical Services ...

More documents

Recommendations

Info

Annexure–I and should be securely tied or bound. Non submission of any of the documents will result in the rejection of the offer. 5.10.3 The Earnest Money Deposit, IF NOT EXEMPTED, shall be Rs.25,000/-. The Earnest Money Deposit shall be paid in the form of Demand Draft favouring Managing Director, Kerala Medical Services Corporation Limited, payable at Thiruvananthapuram / bank guarantee (as per format attached in Annexure-III) valid for a period of 180 days from the date of opening of the technical document. The EMD should be sent with the tender form. EMD in the form of Cheque / Cash / Postal Order will not be accepted. The EMD will not earn interest. 5.10.4 Notary Attested Photocopy of approval of Drugs Control Authority for testing of Drugs, duly renewed up to date. 5.10.5 Income tax statement for the last three financial years. 5.10.6 Notary attested copy of PAN. 5.10.7 Service Tax Clearance Certificate issued by the concerned authority and attested copy of certificate of registration for service tax. 5.10.8 Notary attested copies of audited Balance Sheet and Profit and Loss account for three years i.e. 2009-2010, 2010-2011 and 2011-2012. 5.10.9 Documentary evidence for Constitution of company/concern such as Memorandum and Articles of Association along with notary attested copies of Form 32 whenever there is a change of Directors, Latest Partnership deed (Notary attested copy) etc. with details of the Name, address, Telephone Number, Fax Number, e-mail address of the firm and of the Managing Director / Partners / Proprietor. 5.10.10 Application form with all relevant documents (Annexure – II). 5.10.11 The list of qualified personnel employed in the laboratory [Annexure-II (a)] 5.10.12 The list of sophisticated instruments available in the laboratory. [Annexure II (b)] 5.10.13 Micro Biological facilities available in the laboratory. [Annexure II (c)] 5.10.14 List of Reference standards available in the lab. 5.10.15 Duly filled performance statement in Annexure IV. 5.10.16 Annual turn over statement certified by the auditors for last three years i.e., 2009-2010, 2010-2011 and 2011-2012 as in (Annexure-V) KMSCL: EOI for Empanelment of Drug testing Laboratories Page 15
5.10.17 Declaration in the Proforma given in Annexure-VI duly signed and notarized. 5.10.18 Details of Laboratory in Annexure–VII. 5.10.19 Consent letter of the offerer as in Annexure VIII, giving the details of the Drug / Items offered to be tested in compliance with the EOI conditions and the consent for testing the Drugs / Items at the rates specified in Appendix. 5.10.20 EOI document signed by the offerer in all pages with office seal. 5.10.21 The offer document should reach the Managing Director, Kerala Medical Services Corporation Limited on or before 11 A.M on 27/11/2012. 5.11 Method of Submission of EOI 5.11.1 The EOI shall be sent by registered post or by courier to the above address or dropped in a box specifically kept at the Head Office of Kerala Medical Services Corporation Ltd at Thycaud, Thiruvananthapuram -14. 5.11.2 EOI sent by telex or fax or email is void. 5.12 Deadline for submission of EOI 5.12.1 EOI must be received in the office of the Corporation at the address mentioned in Clause 2.16 not later than the time and date specified in the EOI Schedule (Section III). 5.12.2 In the event of the specified date for submission of EOI being declared holiday, the tender shall be received up to the appointed time on the next working day. 5.12.3 If the EOI is sent by Registered post or by Courier, it should reach the above office on or before the time and date stipulated for the receipt of EOI. The Corporation shall not be held liable for the delay in transit where the EOI is sent by post or courier. 5.12.4 The Corporation may, at its discretion, extend the deadline for submission of EOI by amending the EOI Document, in which case, all rights and obligations of the Corporation and the offerers previously subjected to the deadline shall thereafter be subjected to the same deadline so extended. KMSCL: EOI for Empanelment of Drug testing Laboratories Page 16
Page 1 and 2: KERALA MEDICAL SERVICES CORPORATION
Page 3 and 4: SECTION I INTRODUCTION 1.1. The Ker
Page 5 and 6: SECTION - II INVITATION OF EXPRESSI
Page 7 and 8: 2.16. The EOI Responder must submit
Page 9 and 10: 4.1 Time Limits Prescribed: SECTION
Page 11 and 12: 5.1 Contents of the EOI Document: S
Page 13 and 14: 5.4.10 A prospective offerer requir
Page 15: 5.7.4 It is also an opportunity for
Page 19 and 20: opening of the envelopes before the
Page 21 and 22: 5.17.7 The availability of technica
Page 23 and 24: 5.22 Notification of Award/Letter o
Page 25 and 26: 5.24.6 Corporation will release the
Page 27 and 28: egard shall be in writing and the C
Page 29 and 30: testing fees at artificial non-comp
Page 31 and 32: 5.33.1 Nothing contained in this Co
Page 33 and 34: ANNEXURES KMSCL: EOI for Empanelmen
Page 35 and 36: EOI Cost EMD 12. Annexure VII - Det
Page 37 and 38: No.4.2.8 (Provide contact details l
Page 39 and 40: ANNEXURE- II (b) Ref. Clause No.5.1
Page 41 and 42: ANNEXURE-III Ref. Clause No.5.10.3
Page 43 and 44: PROFORMA FOR PERFORMANCE STATEMENT
Page 45 and 46: DECLARATION FORM ANNEXURE-VI Ref. C
Page 47 and 48: CONSENT LETTER OF THE OFFERER From,
Page 49 and 50: liability under this guarantee and
Page 51 and 52: And whereas the Laboratory has depo
Page 53 and 54: which bank details shall be furnish
Page 55 and 56: 14. In the event of any disputes be
Page 57 and 58: 39 D04017 Bupivacaine In Dextrose I
Page 59 and 60: 101 D18007/ Electrolyte P(Multi Inj
Page 61 and 62: 160 D02025 Metronidazole IP. Inj 5
Page 63 and 64: 228 D03001 Theophylline and Etophyl
Page 65 and 66: 40 S27050 Endotracheal Tube 5.0 1 U
Page 67 and 68:
19 S27004 Hypo Allergic Acrylic Pap
Page 69 and 70:
25 S27572 26 S27531 27 S27574 28 S2
Page 71 and 72:
DETAILS OF LABRATES FOR THE DRUGS A
Page 73 and 74:
45 D11006 Cabergoline tab Tab 0.5mg
Page 75 and 76:
88 D01028 Diclofenac sodium Gel Gel
Page 77 and 78:
126 D02074 Hpylori kit Each combi p
Page 79 and 80:
163 D04026 Lignocaine topical Spray
Page 81 and 82:
207 D24052 Octreotide Inj Inj 50 mc
Page 83 and 84:
255 D08028 Pyrantel Palmoate Syrup
Page 85:
302 D20037 Ursodeoxycholic Acid Tab
show all

empanelment of drug testing laboratories - Kerala Medical Services ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?